Vertex Pharmaceuticals

NASDAQ: VRTX · Real-Time Price · USD
394.23
3.93 (1.01%)
At close: Aug 15, 2025, 12:46 PM

Vertex Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.57B 10.37B 10.5B 6.79B
Short-Term Investments
1.55B 849.2M 274.5M 729.9M
Long-Term Investments
5.11B 2.5B 112.2M n/a
Other Long-Term Assets
999.3M 895.3M 409.6M 110.8M
Receivables
1.61B 1.56B 1.44B 1.14B
Inventory
1.21B 738.8M 460.6M 353.1M
Other Current Assets
206.5M 86.1M 121.9M 103.7M
Total Current Assets
9.6B 14.14B 13.23B 9.56B
Property-Plant & Equipment
2.58B 1.45B 1.46B 1.42B
Goodwill & Intangibles
1.91B 1.93B 1.69B 1.4B
Total Long-Term Assets
12.94B 8.59B 4.92B 3.87B
Total Assets
22.53B 22.73B 18.15B 13.43B
Account Payables
413M 364.9M 303.9M 195M
Deferred Revenue
206.8M 170.3M 159.6M 171.7M
Short-Term Debt
92.3M 83.7M 89.4M 80.2M
Other Current Liabilities
-60.9M -33M -26.9M -63.7M
Total Current Liabilities
3.56B 3.55B 2.74B 2.14B
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
901.8M 877.7M 685.8M 303.3M
Total Long-Term Liabilities
2.56B 1.6B 1.5B 1.19B
Total Liabilities
6.12B 5.15B 4.24B 3.33B
Total Debt
1.75B 808.4M 899.7M 967.4M
Common Stock
2.6M 2.6M 2.6M 2.5M
Retained Earnings
9.61B 10.14B 6.52B 3.2B
Comprehensive Income
127.8M -14.3M 800K 15.9M
Shareholders Equity
16.41B 17.58B 13.91B 10.1B
Total Investments
6.65B 3.35B 386.7M 729.9M